Inogen Inc
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $348.7M | $335.7M | $315.7M | $377.2M | $358.0M |
| Cost of revenue | $163.8M | $148.7M | $158.6M | $197.8M | $161.8M |
| Gross profit | $154.3M | $154.7M | $126.7M | $153.5M | $176.5M |
| Research and development | $19.4M | $21.6M | $20.8M | $21.9M | $16.6M |
| Operating expenses | $184.5M | $197.3M | $236.1M | $238.8M | $167.2M |
| Operating income | -$30.2M | -$42.5M | -$109.4M | -$85.2M | $9.2M |
| Pretax income | -$23.4M | -$36.5M | -$102.3M | -$83.3M | $8.7M |
| Income tax expense | -$632,000 | -$588,000 | $105,000 | $504,000 | $15.0M |
| Net income | -$22.7M | -$35.9M | -$102.4M | -$83.8M | -$6.3M |
| Balance Sheet | |||||
| Cash and equivalents | $103.7M | $113.8M | $125.5M | $187.0M | $235.5M |
| Current assets | $198.3M | $185.5M | $207.1M | $304.6M | $329.2M |
| Total assets | $298.6M | $296.2M | $326.2M | $405.0M | $489.5M |
| Current liabilities | $63.5M | $76.7M | $72.5M | $65.3M | $61.5M |
| Total liabilities | $106.4M | $122.3M | $121.4M | $107.6M | $119.3M |
| Stockholders' equity | $192.2M | $173.9M | $204.8M | $297.4M | $370.2M |
| Cash Flow Statement | |||||
| Cash from operations | -$11.2M | $5.9M | -$3.2M | -$37.5M | $23.6M |
| Depreciation and amortization | $20.7M | $21.0M | $18.2M | $23.5M | $21.6M |
| Stock-based compensation | $8.0M | $7.4M | $7.4M | $12.3M | $10.9M |
| Capital expenditure | $2.5M | $3.4M | $5.2M | $3.3M | $5.5M |
| Free cash flow | -$13.7M | $2.6M | -$8.5M | -$40.9M | $18.2M |
| Impairments | $0 | $0 | $32.9M | $0 | $0 |
Shares outstanding 27.1M · Free float 83.9%
Annual filing data through FY ended December 31, 2025; float as of July 12, 2026.